Abstract
Topical medicaments are the mainstay of the dermatologists’ therapeutic arsenal. Laser-assisted drug delivery enhances the ability of topically applied medicaments to penetrate the skin. We discuss the mechanisms of laser-assisted drug delivery and animal models that have informed clinical practice. We review clinical studies that have employed laser-assisted drug delivery for a range of indications to date including non-melanoma skin cancer, vitiligo, scarring, vaccination, local anaesthesia, analgesia, viral warts, infantile haemangiomas and cosmetic uses. Studies thus far suggest that laser pre-treatment improves transepidermal absorption of topical agents and allows for a much deeper penetration of drugs than is possible with topical medicaments alone. This may allow more efficacious action of current treatments, such that conventional duration of treatment can be shortened or lower concentrations of active agents be used, potentially obviating side effects of treatment. The prospect of using laser technologies to facilitate transdermal vaccination and as an adjunct for inflammatory dermatoses and cosmetic indications remains in its infancy. As larger trials are published, involving greater numbers of patients and utilising various laser and topical medicament parameters, we will enhance our understanding of this nascent modality of treatment delivery.
Similar content being viewed by others
References
Bloom BS, Brauer JA, Geronemus RG (2013) Ablative fractional resurfacing in topical drug delivery: an update and outlook. Dermatol Surg 39:839–848. doi:10.1111/dsu.12111
Sklar LR, Burnett CT, Waibel JS et al (2014) Laser assisted drug delivery: a review of an evolving technology. Lasers Surg Med 46:249–262. doi:10.1002/lsm.22227
Brauer JA, Krakowski AC, Bloom BS et al (2014) Convergence of anatomy, technology, and therapeutics: a review of laser-assisted drug delivers. Semin Cutan Med Surg 33:176–181, doi: 10.12788/j.sder.0119
Bos JD, Meinardi MM (2000) The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol 9:165–169
Stumpp OF, Bedi VP, Wyatt D et al (2009) In vivo confocal imaging of epidermal cell migration and dermal changes post nonablative fractional resurfacing: study of the wound healing process with corroborated histopathologic evidence. J Biomed Opt 14:024018. doi:10.1117/1.3103316
Brisson P (1974) Percutaneous absorption. Can Med Assoc J 110:1182–1185
Wlodek C, Ali FR, Lear JT (2013) Use of photodynamic therapy for treatment of actinic keratoses in organ transplant recipients. BioMed Res Int 2013:349526. doi:10.1155/2013/349526
Haedersdal M, Sakamoto FH, Farinelli WA et al (2010) Fractional CO(2) laser-assisted drug delivery. Lasers Surg Med 42:113–122. doi:10.1002/lsm.20860
Bachhav YG, Summer S, Heinrich A et al (2010) Effect of controlled laser microporation on drug transport kinetics into and across the skin. J Controlled Release 146:31–36. doi:10.1016/j.jconrel.2010.05.025
Haedersdal M, Katsnelson J, Sakamoto FH et al (2011) Enhanced uptake and photoactivation of topical methyl aminolevulinate after fractional CO2 laser pretreatment. Lasers Surg Med 43:804–813. doi:10.1002/lsm.21096
Haak CS, Farinelli WA, Tam J et al (2012) Fractional laser-assisted delivery of methyl aminolevulinate: impact of laser channel depth and incubation time. Lasers Surg Med 44:787–795. doi:10.1002/lsm.22102
Haedersdal M, Sakamoto FH, Farinelli WA et al (2014) Pretreatment with ablative fractional laser changes kinetics and biodistribution of topical 5-aminolevulinic acid (ALA) and methyl aminolevulinate (MAL). Lasers Surg Med 46:462–469. doi:10.1002/lsm.22259
Lee W-R, Shen S-C, Wang K-H et al (2002) The effect of laser treatment on skin to enhance and control transdermal delivery of 5-fluorouracil. J Pharm Sci 91:1613–1626. doi:10.1002/jps.10142
Lee W-R, Shen S-C, Suwayeh SA A et al (2011) Laser-assisted topical drug delivery by using a low-fluence fractional laser: imiquimod and macromolecules. J Controlled Release 153:240–248. doi:10.1016/j.jconrel.2011.03.015
Ali FR, Wlodek C, Lear JT (2012) The role of ingenol mebutate in the treatment of actinic keratoses. Dermatol Ther 2:8. doi:10.1007/s13555-012-0008-4
Karmisholt KE, Haedersdal M (2015) Ablative fractional laser intensifies treatment outcome of scalp actinic keratoses with ingenol mebutate: a case report. J Eur Acad Dermatol Venereol JEADV. doi:10.1111/jdv.13021
Helsing P, Togsverd-Bo K, Veierød MB et al (2013) Intensified fractional CO2 laser-assisted photodynamic therapy vs. laser alone for organ transplant recipients with multiple actinic keratoses and wart-like lesions: a randomized half-side comparative trial on dorsal hands. Br J Dermatol 169:1087–1092. doi:10.1111/bjd.12507
Song HS, Jung S-E, Jang YH et al (2015) Fractional carbon dioxide laser-assisted photodynamic therapy for patients with actinic keratosis. Photodermatol Photoimmunol Photomed. doi:10.1111/phpp.12184
Braun SA, Hevezi P, Homey B, Gerber PA (2015) Laser-assisted drug delivery: enhanced response to ingenol mebutate after ablative fractional laser treatment. J Am Acad Dermatol 72:364–365. doi:10.1016/j.jaad.2014.09.055
Kim SK, Park J-Y, Song HS et al (2013) Photodynamic therapy with ablative carbon dioxide fractional laser for treating Bowen disease. Ann Dermatol 25:335–339. doi:10.5021/ad.2013.25.3.335
Ko DY, Kim KH, Song KH (2014) A randomized trial comparing methyl aminolaevulinate photodynamic therapy with and without Er:YAG ablative fractional laser treatment in Asian patients with lower extremity Bowen disease: results from a 12-month follow-up. Br J Dermatol 170:165–172. doi:10.1111/bjd.12627
Nguyen BT, Gan SD, Konnikov N, Liang CA (2015) Treatment of superficial basal cell carcinoma and squamous cell carcinoma in situ on the trunk and extremities with ablative fractional laser-assisted delivery of topical fluorouracil. J Am Acad Dermatol 72:558–560. doi:10.1016/j.jaad.2014.11.033
Peng Q, Warloe T, Berg K et al (1997) 5-Aminolevulinic acid-based photodynamic therapy. Clinical research and future challenges Cancer 79:2282–2308
Telfer NR, Colver GB, Morton CA, British Association of Dermatologists (2008) Guidelines for the management of basal cell carcinoma. Br J Dermatol 159:35–48. doi:10.1111/j.1365-2133.2008.08666.x
Haedersdal M, Togsverd-Bo K, Paasch U (2012) Case reports on the potential of fractional laser-assisted photodynamic therapy for basal cell carcinomas. Lasers Med Sci 27:1091–1093. doi:10.1007/s10103-011-1041-8
Lippert J, Smucler R, Vlk M (2013) Fractional carbon dioxide laser improves nodular basal cell carcinoma treatment with photodynamic therapy with methyl 5-aminolevulinate. Dermatol Surg 39:1202–1208. doi:10.1111/dsu.12242
Haak CS, Togsverd-Bo K, Thaysen-Petersen D et al (2015) Fractional laser-mediated photodynamic therapy of high-risk basal cell carcinomas—a randomized clinical trial. Br J Dermatol 172:215–222. doi:10.1111/bjd.13166
Choi SH, Kim KH, Song K-H (2015) Efficacy of ablative fractional laser-assisted photodynamic therapy for the treatment of actinic cheilitis: 12-month follow-up results of a prospective, randomized, comparative trial. Br J Dermatol 173:184–191. doi:10.1111/bjd.13542
Markopoulos A, Albanidou-Farmaki E, Kayavis I (2004) Actinic cheilitis: clinical and pathologic characteristics in 65 cases. Oral Dis 10:212–216. doi:10.1111/j.1601-0825.2004.01004.x
Bachhav YG, Heinrich A, Kalia YN (2013) Controlled intra- and transdermal protein delivery using a minimally invasive erbium:YAG fractional laser ablation technology. Eur J Pharm Biopharm 84:355–364. doi:10.1016/j.ejpb.2012.11.018
Chen X, Wang J, Shah D, Wu MX (2013) An update on the use of laser technology in skin vaccination. Expert Rev Vaccines 12:1313–1323. doi:10.1586/14760584.2013.844070
Lee W-R, Shen S-C, Fang C-L et al (2007) Skin pretreatment with an Er:YAG laser promotes the transdermal delivery of three narcotic analgesics. Lasers Med Sci 22:271–278. doi:10.1007/s10103-007-0452-z
Qu L, Liu A, Zhou L et al (2012) Clinical and molecular effects on mature burn scars after treatment with a fractional CO(2) laser. Lasers Surg Med 44:517–524. doi:10.1002/lsm.22055
Singer AJ, Weeks R, Regev R (2006) Laser-assisted anesthesia reduces the pain of venous cannulation in children and adults: a randomized controlled trial. Acad Emerg Med 13:623–628. doi:10.1197/j.aem.2006.01.016
Koh JL, Harrison D, Swanson V et al (2007) A comparison of laser-assisted drug delivery at two output energies for enhancing the delivery of topically applied LMX-4 cream prior to venipuncture. Anesth Analg 104:847–849. doi:10.1213/01.ane.0000257925.36641.9e
Meesters AA, Bakker MM, de Rie MA, Wolkerstorfer A (2015) Fractional CO2 laser assisted delivery of topical anesthetics: a randomized controlled pilot study. Lasers Surg Med. doi:10.1002/lsm.22376
Yun PL, Tachihara R, Anderson RR (2002) Efficacy of erbium:yttrium-aluminum-garnet laser-assisted delivery of topical anesthetic. J Am Acad Dermatol 47:542–547
Waibel JS, Wulkan AJ, Shumaker PR (2013) Treatment of hypertrophic scars using laser and laser assisted corticosteroid delivery. Lasers Surg Med 45:135–140. doi:10.1002/lsm.22120
Cavalié M, Sillard L, Montaudié H et al (2015) Treatment of keloids with laser-assisted topical steroid delivery: a retrospective study of 23 cases. Dermatol Ther 28:74–78. doi:10.1111/dth.12187
Rkein A, Ozog D, Waibel JS (2014) Treatment of atrophic scars with fractionated CO2 laser facilitating delivery of topically applied poly-L-lactic acid. Dermatol Surg 40:624–631. doi:10.1111/dsu.0000000000000010
de Graaf M, Breur JMPJ, Raphaël MF et al (2011) Adverse effects of propranolol when used in the treatment of hemangiomas: a case series of 28 infants. J Am Acad Dermatol 65:320–327. doi:10.1016/j.jaad.2010.06.048
Ma G, Wu P, Lin X et al (2014) Fractional carbon dioxide laser-assisted drug delivery of topical timolol solution for the treatment of deep infantile hemangioma: a pilot study. Pediatr Dermatol 31:286–291. doi:10.1111/pde.12299
Yoo KH, Kim BJ, Kim MN (2009) Enhanced efficacy of photodynamic therapy with methyl 5-aminolevulinic acid in recalcitrant periungual warts after ablative carbon dioxide fractional laser: a pilot study. Dermatol Surg 35:1927–1932. doi:10.1111/j.1524-4725.2009.01307.x
Trelles MA, Leclère FM, Martínez-Carpio PA (2013) Fractional carbon dioxide laser and acoustic-pressure ultrasound for transepidermal delivery of cosmeceuticals: a novel method of facial rejuvenation. Aesthetic Plast Surg 37:965–972. doi:10.1007/s00266-013-0176-3
Mahmoud BH, Burnett C, Ozog D (2015) Prospective randomized controlled study to determine the effect of topical application of Botulinum toxin a for crow’s feet after treatment with ablative fractional CO2 laser. Dermatol Surg 41:S75–S81. doi:10.1097/01.DSS.0000452642.83894.ab
Brandt F, O’Connell C, Cazzaniga A, Waugh JM (2010) Efficacy and safety evaluation of a novel botulinum toxin topical gel for the treatment of moderate to severe lateral canthal lines. Dermatol Surg 36:2111–2118. doi:10.1111/j.1524-4725.2010.01711.x
Lim HK, Jeong KH, Kim NI, Shin MK (2014) Nonablative fractional laser as a tool to facilitate skin penetration of 5-aminolaevulinic acid with minimal skin disruption: a preliminary study. Br J Dermatol 170:1336–1340. doi:10.1111/bjd.12817
Marra DE, Yip D, Fincher EF, Moy RL (2006) Systemic toxicity from topically applied lidocaine in conjunction with fractional photothermolysis. Arch Dermatol 142:1024–1026. doi:10.1001/archderm.142.8.1024
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
Dr. Ali and Dr. Al-Niaimi declare no conflicts of interest.
Rights and permissions
About this article
Cite this article
Ali, F.R., Al-Niaimi, F. Laser-assisted drug delivery in dermatology: from animal models to clinical practice. Lasers Med Sci 31, 373–381 (2016). https://doi.org/10.1007/s10103-015-1853-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10103-015-1853-z